{"id":"NCT01764633","sponsor":"Amgen","briefTitle":"Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk","officialTitle":"A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab (AMG 145) is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-02-08","primaryCompletion":"2016-11-11","completion":"2016-11-11","firstPosted":"2013-01-09","resultsPosted":"2018-02-15","lastUpdate":"2024-05-28"},"enrollment":27564,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Dyslipidemia"],"interventions":[{"type":"BIOLOGICAL","name":"Evolocumab","otherNames":["AMG 145","Repatha"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Evolocumab","type":"EXPERIMENTAL"}],"summary":"The primary objective was to evaluate the effect of treatment with evolocumab, compared with placebo, on the risk for cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization, whichever occurs first, in patients with clinically evident cardiovascular disease.","primaryOutcome":{"measure":"Time to Cardiovascular Death, Myocardial Infarction, Hospitalization for Unstable Angina, Stroke, or Coronary Revascularization","timeFrame":"Events that occurred from randomization to the last confirmed survival status date; the median duration of follow-up was 26 months. KM estimates at 6, 12, 18, 24, 30 and 36 months are reported.","effectByArm":[{"arm":"Placebo","deltaMin":3.11,"sd":null},{"arm":"Evolocumab","deltaMin":2.74,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"< 0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":6},"locations":{"siteCount":1284,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Canada","Chile","China","Colombia","Czechia","Denmark","Estonia","Finland","France","Germany","Greece","Hong Kong","Hungary","Iceland","India","Ireland","Israel","Italy","Japan","Latvia","Lithuania","Malaysia","Mexico","Netherlands","New Zealand","Norway","Philippines","Poland","Portugal","Romania","Russia","Singapore","Slovakia","South Africa","South Korea","Spain","Sweden","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["28304224","28832867","31166576","35760720","37344040","40255182","36779348","36585131","36007987","35209731","34537830","33980763","33197560","33078867","32785614","32432684","32347887","32347885","32312223","31196453","31116355","30586750","30540337","29898218","29626068","29530884","29133605","28927706","28859947"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":3404,"n":13756},"commonTop":["Diabetes mellitus","Hypertension","Nasopharyngitis","Upper respiratory tract infection"]}}